Compare LTGO & WLTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | LTGO | WLTH |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Finance: Consumer Services |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2026 | 2025 |
| Metric | LTGO | WLTH |
|---|---|---|
| Price | $20.25 | $9.82 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $12.86 |
| AVG Volume (30 Days) | 226.7K | ★ 2.6M |
| Earning Date | N/A | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.18 |
| Revenue | N/A | ★ $364,993,000.00 |
| Revenue This Year | N/A | $10.58 |
| Revenue Next Year | N/A | $23.43 |
| P/E Ratio | ★ N/A | $55.22 |
| Revenue Growth | N/A | ★ 18.17 |
| 52 Week Low | $17.22 | $7.20 |
| 52 Week High | $25.93 | $14.12 |
| Indicator | LTGO | WLTH |
|---|---|---|
| Relative Strength Index (RSI) | 46.32 | 50.80 |
| Support Level | N/A | $8.72 |
| Resistance Level | $25.17 | $9.87 |
| Average True Range (ATR) | 1.68 | 0.52 |
| MACD | -0.38 | -0.02 |
| Stochastic Oscillator | 15.87 | 37.88 |
Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.
Wealthfront Corp is a product-driven technology company that built a financial solutions platform for digital natives. The platform is designed to address the needs of the wealth builders within these generations. Its business model is designed to optimize for clients' success. The focus on delivering fully automated services results in being one of the lowest cost producers in each category in which participate. The group generates revenue from cash management and investment advisory products. Cash management revenue is earned from fees received for the delivery of cash management services, including the cash sweep program.